Related Experiment Video
Updated: Jul 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates
Julina Ongkasuwan1, Tulio A Valdez, Kristina G Hulten
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.
Insights
The pneumococcal conjugate vaccine
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Otolaryngology
Background:
- Pneumococcal mastoiditis is a serious complication of otitis media in children.
- The pneumococcal conjugate vaccine (PCV) was introduced to reduce the burden of invasive pneumococcal disease.
- Serotype 19A has emerged as a significant pathogen in invasive pneumococcal disease following PCV introduction.
Purpose of the Study:
- To evaluate the impact of the pneumococcal conjugate vaccine on pneumococcal mastoiditis in children.
- To identify changes in serotype prevalence and clinical characteristics of pneumococcal mastoiditis post-vaccine introduction.
Main Methods:
- Retrospective review of medical charts of children with pneumococcal mastoiditis from 1995 to 2007.
- Serotyping of pneumococcal isolates using the capsular swelling method.
- Pulsed-field gel electrophoresis and multilocus sequence typing for characterizing 19A isolates.
Main Results:
- Serotype 19A became the predominant cause of pneumococcal mastoiditis after PCV introduction.
- Cases caused by 19A were more likely to present with subperiosteal abscess and require mastoidectomy.
- Multidrug resistance was common in 19A isolates, associated with clonal complex 271.
Conclusions:
- Serotype 19A, particularly multidrug-resistant strains of clonal complex 271, has emerged as a leading cause of pneumococcal mastoiditis in children.
- Pneumococcal mastoiditis due to 19A is associated with more severe clinical presentations, including subperiosteal abscesses and increased need for mastoidectomy.
Objective:
We review the impact of pneumococcal conjugate vaccine on pneumococcal mastoiditis in children at Texas Children's Hospital.
Methods:
The medical charts (including the number of pneumococcal conjugate vaccine doses) for children with pneumococcal mastoiditis treated at Texas Children's Hospital between January 1995 and June 2007 were reviewed retrospectively. Isolates were serotyped with the capsular swelling method. Pulsed-field gel electrophoresis was performed on the 19A isolates and multilocus sequence typing on selected 19A clones.
Results:
Forty-one pneumococcal mastoiditis cases were identified, and 19A (n = 19) was the most common serotype. Before the introduction of pneumococcal conjugate vaccine (from 1995 to December 1999), 0 of 12 cases were 19A. Between April 2000 and October 2006, 15 cases of pneumococcal mastoiditis occurred, and 5 were 19A. Fourteen cases of pneumococcal mastoiditis occurred between November 2006 and June 2007, all of which were 19A. Mastoiditis caused by 19A isolates was more likely to present with subperiosteal abscess and was more likely to need intraoperative mastoidectomy than was mastoiditis caused by non-19A isolates. Multidrug resistance was also common among the 19A isolates; 13 (68%) of the 19A isolates were resistant to all antibiotics tested routinely. Pulsed-field gel electrophoresis analysis placed 14 (74%) of the 19 serotype 19A isolates into a highly related group; 12 isolates were classified as closely related, and 2 were possibly related. Multilocus sequence typing analysis placed the pulsed-field gel electrophoresis cluster isolates into clonal complex 271 (sequence types 320 and 1451).
Conclusions:
At Texas Children's Hospital, 19A has become the predominant serotype causing pneumococcal mastoiditis, partly related to the emergence of multidrug-resistant clonal complex 271 strains. Subperiosteal abscesses and the need for mastoidectomy were more common in children with mastoiditis caused by serotype 19A isolates, compared with isolates of other serotypes.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis I: Introduction
Atypical Pneumonia
